Spots Global Cancer Trial Database for adult solid tumor
Every month we try and update this database with for adult solid tumor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Cancer Therapy | NCT04538625 | Cancer Therapy-... Chemotherapy-re... Adult Solid Tum... Prophylaxis of ... Symptomatic Rel... Targeted Therap... | Crofelemer 125 ... Placebo | 18 Years - | Napo Pharmaceuticals, Inc. | |
| Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) | NCT02568267 | Breast Cancer Cholangiocarcin... Colorectal Canc... Head and Neck N... Lymphoma, Large... Melanoma Neuroendocrine ... Non-Small Cell ... Ovarian Cancer Pancreatic Canc... Papillary Thyro... Primary Brain T... Renal Cell Carc... Sarcomas Salivary Gland ... Adult Solid Tum... | Entrectinib | 18 Years - | Hoffmann-La Roche | |
| Combining Epigenetic And Immune Therapy to Beat Cancer. | NCT04705818 | Advanced Solid ... Advanced Colore... Advanced Soft-t... Advanced Pancre... Adult Solid Tum... | Durvalumab Tazemetostat | 18 Years - | Institut Bergonié | |
| Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery | NCT00041171 | Adult Solid Tum... Breast Cancer Head and Neck C... Kidney and Urin... Male Reproducti... Thorax and Resp... | Hypericum perfo... docetaxel placebo | 18 Years - 120 Years | Alliance for Clinical Trials in Oncology | |
| A Phase I Study of LTC004 Combin With FC in Patients With Advanced/Metastatic Malignancies Tumor | NCT06277804 | Adult Solid Tum... | LTC004 in Combi... | 18 Years - 75 Years | Letolab | |
| Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors | NCT03061305 | Cancer Adult Solid Tum... Lymphoma Multiple Myelom... | 18 Years - | Strata Oncology | ||
| Study of RP-6306 With Gemcitabine in Advanced Solid Tumors | NCT05147272 | Adult Solid Tum... | RP-6306 (oral P... | 18 Years - | Repare Therapeutics | |
| A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors | NCT06403436 | Advanced Solid ... Adult Solid Tum... Adult Disease Cancer | TT125-802 | 18 Years - | TOLREMO therapeutics AG | |
| A Comparison of Remifentanil and Dexmedetomidine for Craniotomy Perioperative Hemodynamics and Postoperative Pain | NCT01269918 | Adult Intracran... Adult Solid Tum... | Remifentanil Dexmedetomidine | 18 Years - 80 Years | The Cleveland Clinic | |
| Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Indicated | NCT01332721 | Adult Solid Tum... | TRC105 and Beva... | 18 Years - | Tracon Pharmaceuticals Inc. | |
| A Phase I Study of LTC004 Combin With FC in Patients With Advanced/Metastatic Malignancies Tumor | NCT06277804 | Adult Solid Tum... | LTC004 in Combi... | 18 Years - 75 Years | Letolab | |
| Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Indicated | NCT01332721 | Adult Solid Tum... | TRC105 and Beva... | 18 Years - | Tracon Pharmaceuticals Inc. | |
| Cyberknife Radiosurgery for Patients With Brain Metastases Diagnosed With Either SPACE or MPRAGE Sequence | NCT03303365 | Brain Metastase... Adult Solid Tum... | stereotactic ra... | 18 Years - | University Hospital Heidelberg | |
| A Phase I Study of LTC004 Combin With FC in Patients With Advanced/Metastatic Malignancies Tumor | NCT06277804 | Adult Solid Tum... | LTC004 in Combi... | 18 Years - 75 Years | Letolab | |
| A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors | NCT06403436 | Advanced Solid ... Adult Solid Tum... Adult Disease Cancer | TT125-802 | 18 Years - | TOLREMO therapeutics AG | |
| Study of SQZ-AAC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors | NCT04892043 | Adult Solid Tum... | SQZ-AAC-HPV Ipilimumab Nivolumab | 18 Years - | SQZ Biotechnologies | |
| ASA404 in Combination With Carboplatin/Paclitaxel/Cetuximab in Treating Patients With Refractory Solid Tumors | NCT01031212 | Tumors | ASA404 Cetuximab Carboplatin Paclitaxel | 18 Years - | University of California, San Francisco | |
| Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Cancer Therapy | NCT04538625 | Cancer Therapy-... Chemotherapy-re... Adult Solid Tum... Prophylaxis of ... Symptomatic Rel... Targeted Therap... | Crofelemer 125 ... Placebo | 18 Years - | Napo Pharmaceuticals, Inc. | |
| A Phase I Trial of AZD3965 in Patients With Advanced Cancer | NCT01791595 | Adult Solid Tum... Diffuse Large B... Burkitt Lymphom... | AZD3965 AZD3965 AZD3965 AZD3965 AZD3965 AZD3965 AZD3965 | 18 Years - | Cancer Research UK | |
| Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Cancer Therapy | NCT04538625 | Cancer Therapy-... Chemotherapy-re... Adult Solid Tum... Prophylaxis of ... Symptomatic Rel... Targeted Therap... | Crofelemer 125 ... Placebo | 18 Years - | Napo Pharmaceuticals, Inc. | |
| Study of SQZ-AAC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors | NCT04892043 | Adult Solid Tum... | SQZ-AAC-HPV Ipilimumab Nivolumab | 18 Years - | SQZ Biotechnologies | |
| Study of SQZ-PBMC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors | NCT04084951 | Adult Solid Tum... | SQZ-PBMC-HPV Atezolizumab Ipilimumab Nivolumab | 18 Years - | SQZ Biotechnologies | |
| Neoadjuvant Immunotherapy in Combination With the Anti-GDF-15 Antibody Visugromab (CTL-002) for Treatment of Muscle Invasive Bladder Cancer | NCT06059547 | Bladder Cancer Adult Solid Tum... | Nivolumab Visugromab (CTL... Placebo | 18 Years - | CatalYm GmbH | |
| Human Leukocyte Antigen Typing and Tumor Antigen Expression Profiling | NCT03760952 | Refractory Canc... Recurrent Cance... Adult Solid Tum... Neoplasms | 18 Years - | Immatics US, Inc. | ||
| A Comparison of Remifentanil and Dexmedetomidine for Craniotomy Perioperative Hemodynamics and Postoperative Pain | NCT01269918 | Adult Intracran... Adult Solid Tum... | Remifentanil Dexmedetomidine | 18 Years - 80 Years | The Cleveland Clinic | |
| Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of HLX26 and HLX10 in Patients With Advanced/Metastatic Solid Tumor | NCT05400265 | Adult Solid Tum... | HLX26 HLX10 | 18 Years - 75 Years | Shanghai Henlius Biotech | |
| Hydrogen Gas for Cancer Rehabilitation | NCT03818347 | Adult Solid Tum... | oxyhydrogen gen... analogue machin... | 30 Years - 80 Years | Fuda Cancer Hospital, Guangzhou | |
| Study of SQZ-eAPC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors | NCT05357898 | Adult Solid Tum... | SQZ-eAPC-HPV Pembrolizumab | 18 Years - | SQZ Biotechnologies | |
| CANscriptTM Clinical Outcomes in a Real-World Setting (ANCERS)-2 | NCT03253575 | Adult Solid Tum... | CANscript | 18 Years - | Mitra RxDx, Inc. | |
| A Phase I Trial of AZD3965 in Patients With Advanced Cancer | NCT01791595 | Adult Solid Tum... Diffuse Large B... Burkitt Lymphom... | AZD3965 AZD3965 AZD3965 AZD3965 AZD3965 AZD3965 AZD3965 | 18 Years - | Cancer Research UK |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
